The Global Microarray Analysis Market is expected to grow at a CAGR 9.8% during the forecast period 2017-2023. Microarrays are a powerful approach for the analysis of gene expression that can be used for various experimental purposes. Numerous types of microarray platforms are available for testing. Development of microarrays had improved results of genetic testing.
Microarray is an advanced molecular biology technique, used to spot expressions of many genes at the same time. Any abnormalities in gene functioning can lead to a critical disease. Microarrays serves a good platform for the diagnosis and development of treatment for this type of diseases. Microarray can be used for many micro molecules such as DNA, RNA, proteins, enzymes, carbohydrates, and tissues. Global microarray analysis market is majorly driven by the rapid development in the genetics, increasing prevalence of cancer and rising need of research. Increasing prevalence of chronic diseases, increasing healthcare expenditure and continuous development in the technology has propelled the market’s growth. However, high cost of the tests may slower this market’s growth.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/777
The Global Microarrays Analysis Industry is majorly driven by the increasing prevalence of cancer and rising need of research in pharmaceutical industries. Increasing prevalence of different chronic diseases, use of this techniques for the diagnosis of infectious diseases, development in the field of genetics and increasing healthcare expenditure; all these together have provided a push for this market’s growth. However, high cost of tests and need of high tech instruments may restrain growth of this market.
Key Players
Among many layers, some of the key player in the market are QIAGEN (Germany), Thermo Fisher Scientific, Inc. (US), Agilent Technologies (US), Applied Micro Arrays (US), Merck Sharp & Dohme Corp (US), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Illumina, Inc. (US), Arrayit Corporation (US), BioGenex (US) and General Electric Company (UK).
Segmentation
The Global Microarray Analysis Market is segmented into technology, consumables, services, application and end users.
On the basis of technology, the market is segmented into DNA microarray, PCR, NGS, SAGE, northern blotting and others.
On the basis of consumables, the market is segmented into DNA chips, DNA microarrays, protein microarrays, cellular microarrays, chemical compound microarrays, antibody microarrays and others. On the basis of services, the market is divided into gene profiling, bioinformatics and others.
On the basis of applications, the market is categorized into research, drug discovery, diagnostic and others.
Regional Analysis
America accounts for the largest share in the global microarray analysis market owing to the presence of well-developed healthcare sector and government support for research & development. Europe is the second largest market of global microarray analysis which is followed by Asia Pacific. Presence of large cancer population and increasing need for better diagnostic treatment has driven the European market. Asia Pacific microarray analysis market is majorly occupied by Japan. India and China, these are the growing market of microarray analysis. Middle East & Africa have least share in this market.
Get Discount @ https://www.marketresearchfuture.com/check-discount/777
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The post Top 10 Microarray Analysis Market Players Size and Shares 2023 Forecasts | MRFR appeared first on Herald Keeper.
